Literature DB >> 2642093

Antithrombin III in children with various renal diseases.

H Fukui1, A Taniguchi, S Sakamoto, S Kawahara, T Matsunaga, K Taira, S Tanaka, H Kamitsuji.   

Abstract

Levels of antithrombin III (AT-III) activity and antigen in plasma and urine in children with renal diseases, and their correlation with the light microscopic findings of kidney tissue and the fluorescence of glomeruli, were investigated. AT-III activity in plasma was reduced slightly during the acute stage of acute glomerulonephritis and moderately in the relapse stage of nephrotic syndrome, whereas a small increase of AT-III antigen level in urine was noted in the acute stage of glomerulonephritis and considerably more was observed during the relapse stage of nephrotic syndrome. During the acute stage of glomerulonephritis or in some primary persistent glomerulonephritis (IgA nephritis, non-IgA nephritis), Henoch-Schönlein purpura nephritis and nephrotic syndrome, localization of small amounts of AT-III was noted on the capillary walls of glomeruli. These findings were in parallel with the proliferative changes of glomeruli. However, the AT-III localization did not change in parallel with the light microscopic findings or degree of the fluorescence of the fibrinogen/fibrin-related antigen. It was thought that the existence of AT-III antigen on the capillary walls of the glomeruli might be associated with the inhibition of excessive fibrin formation by AT-III.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2642093     DOI: 10.1007/bf00852896

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  13 in total

1.  INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA.

Authors:  O EGEBERG
Journal:  Thromb Diath Haemorrh       Date:  1965-06-15

2.  Antithrombin III in fresh and cultured human endothelial cells: a natural anticoagulant from the vascular endothelium.

Authors:  V Chan; T K Chan
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

3.  The identification and localization of antithrombin III in human tissues.

Authors:  A K Lee; V Chan; T K Chan
Journal:  Thromb Res       Date:  1979-01       Impact factor: 3.944

Review 4.  Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome.

Authors:  F Llach
Journal:  Kidney Int       Date:  1985-09       Impact factor: 10.612

5.  Acute fatty liver of pregnancy with complicating disseminated intravascular coagulation.

Authors:  B Laursen; L Frost; J Z Mortensen; K B Hansen; S M Paulsen
Journal:  Acta Obstet Gynecol Scand       Date:  1983       Impact factor: 3.636

6.  On the clinical significance of acquired antithrombin deficiency.

Authors:  Y Sørum; G F Handeland; U Abildgaard
Journal:  Folia Haematol Int Mag Klin Morphol Blutforsch       Date:  1984

7.  Low antithrombin III levels in neonates with idiopathic respiratory distress syndrome: poor prognosis.

Authors:  M Peters; J W Ten Cate; C Breederveld; R De Leeuw; J Emeis; J Koppe
Journal:  Pediatr Res       Date:  1984-03       Impact factor: 3.756

8.  Acquired antithrombin III deficiency in patients with glomerular proteinuria.

Authors:  E Thaler; E Balzar; H Kopsa; W F Pinggera
Journal:  Haemostasis       Date:  1978

9.  Antithrombin III and the nephrotic syndrome.

Authors:  K A Jørgensen; E Stoffersen
Journal:  Scand J Haematol       Date:  1979-05

10.  Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome.

Authors:  R H Kauffmann; J J Veltkamp; N H Van Tilburg; L A Van Es
Journal:  Am J Med       Date:  1978-10       Impact factor: 4.965

View more
  3 in total

Review 1.  SerpinC1/Antithrombin III in kidney-related diseases.

Authors:  Zeyuan Lu; Feng Wang; Mingyu Liang
Journal:  Clin Sci (Lond)       Date:  2017-05-01       Impact factor: 6.124

2.  Analysis of the differential urinary protein profile in IgA nephropathy patients of Uygur ethnicity.

Authors:  Zhengguang Guo; Zhao Wang; Chen Lu; Shufen Yang; Haidan Sun; Yu Guo; Wei Sun; Hua Yue
Journal:  BMC Nephrol       Date:  2018-12-14       Impact factor: 2.388

3.  Exploratory evaluation of pharmacodynamics, pharmacokinetics and safety of rivaroxaban in children and adolescents: an EINSTEIN-Jr phase I study.

Authors:  Dagmar Kubitza; Stefan Willmann; Michael Becka; Kirstin Thelen; Guy Young; Leonardo R Brandão; Paul Monagle; Christoph Male; Anthony Chan; Gili Kennet; Ida Martinelli; Paola Saracco; Anthonie W A Lensing
Journal:  Thromb J       Date:  2018-12-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.